BTIG Keeps Their Buy Rating on Intuitive Surgical (ISRG)

BTIG analyst Ryan Zimmerman maintained a Buy rating on Intuitive Surgical (ISRGResearch Report) yesterday and set a price target of $247.00. The company’s shares closed last Thursday at $224.75.

According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 6.8% and a 44.2% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Treace Medical Concepts, and Zimmer Biomet Holdings.

Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $274.33, representing a 24.2% upside. In a report issued on July 6, Bank of America Securities also maintained a Buy rating on the stock with a $250.00 price target.

See the top stocks recommended by analysts >>

Intuitive Surgical’s market cap is currently $78.69B and has a P/E ratio of 48.85.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.

Read More on ISRG:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More